Related Experiment Videos
[Therapy of hepatitis B. Practical implications]
Schweizerische Medizinische Wochenschrift
|April 16, 1977
Summary
Currently, no specific viral hepatitis treatment exists, but prevention strategies like vaccination are advancing. Chronic active hepatitis shows promise with immunosuppressive therapies.
Area of Science:
- Hepatology
- Virology
- Immunology
Context:
- Viral hepatitis lacks specific treatments, necessitating supportive care and isolation.
- Fulminant hepatic failure management remains controversial, with ongoing research into glucocorticoid and serum treatments.
- Chronic active hepatitis presents complex treatment challenges, requiring tailored immunomodulatory approaches.
Purpose:
- To review current management strategies for viral hepatitis, including supportive care, specific therapies for chronic active hepatitis, and emerging prevention methods.
- To evaluate the efficacy of various treatments for different forms of viral hepatitis, from uncomplicated cases to fulminant hepatic failure.
- To explore the potential of active immunization for hepatitis B prevention.
Summary:
- Uncomplicated viral hepatitis requires rest and isolation; fulminant hepatic failure treatment is debated. Chronic active hepatitis responds well to azathioprine and glucocorticoids.
- Immunomodulatory agents like transfer factor, levamisole, and thymosin are under investigation for chronic active hepatitis.
- Hepatitis B prevention through active immunization shows promise, contingent on developing effective vaccine production methods.
Impact:
- Highlights the need for effective viral hepatitis treatments and preventative measures, particularly for hepatitis B.
- Informs clinical practice regarding the management of chronic active hepatitis and fulminant hepatic failure.
- Underscores the critical role of vaccine development in controlling hepatitis B infections.